Cargando…

Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729

NAV2729 is a presumed inhibitor of the monomeric GTPase ADP ribosylation factor 6 (ARF6) and inhibits smooth muscle contraction outside the cardiovascular system. Its effects on vascular smooth muscle contraction or a possible role of ARF6 in vasocontraction have not yet been examined. Here, we repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ru, Li, Bingsheng, Tamalunas, Alexander, Waidelich, Raphaela, Stief, Christian G., Hennenberg, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873054/
https://www.ncbi.nlm.nih.gov/pubmed/35141760
http://dx.doi.org/10.1007/s00210-022-02218-2
_version_ 1784657379618455552
author Huang, Ru
Li, Bingsheng
Tamalunas, Alexander
Waidelich, Raphaela
Stief, Christian G.
Hennenberg, Martin
author_facet Huang, Ru
Li, Bingsheng
Tamalunas, Alexander
Waidelich, Raphaela
Stief, Christian G.
Hennenberg, Martin
author_sort Huang, Ru
collection PubMed
description NAV2729 is a presumed inhibitor of the monomeric GTPase ADP ribosylation factor 6 (ARF6) and inhibits smooth muscle contraction outside the cardiovascular system. Its effects on vascular smooth muscle contraction or a possible role of ARF6 in vasocontraction have not yet been examined. Here, we report effects of NAV2729 on neurogenic and agonist-induced contractions in renal interlobar and coronary arteries. Contractions of pig interlobar and coronary arteries were induced in an organ bath by agonists or by electric field stimulation (EFS). Owing to divergent characteristics of both vessel types, EFS-induced contractions were only examined in interlobar arteries, and contractions by agonists acting on muscarinic receptors only in coronary arteries. NAV2729 inhibited frequency-dependent EFS-induced contractions of interlobar arteries. The degree of inhibition was similar using 5 µM and 10 µM NAV2729. Inhibition of EFS-induced contractions was resistant to a nitric oxide synthase inhibitor and to diclofenac. The neurogenic and adrenergic character of EFS-induced contractions was confirmed by inhibition by tetrodotoxin and prazosin. In coronary arteries, NAV2729 (5 µM) inhibited concentration-dependent contractions induced by carbachol and methacholine. Contractions induced by α(1)-adrenergic agonists, endothelin-1, the thromboxane receptor agonist U46619, or serotonin remained unchanged by NAV2729 in both vessel types. NAV2729 inhibits neurogenic contractions in interlobar arteries and contractions induced by cholinergic agonists in coronary arteries. In both vessel types, NAV2729 does not inhibit contractions induced by receptor agonists other than those acting on muscarinic receptors. Addressing effects in other vessels and in other smooth muscle–rich organs merits further attention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00210-022-02218-2.
format Online
Article
Text
id pubmed-8873054
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88730542022-03-02 Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729 Huang, Ru Li, Bingsheng Tamalunas, Alexander Waidelich, Raphaela Stief, Christian G. Hennenberg, Martin Naunyn Schmiedebergs Arch Pharmacol Original Article NAV2729 is a presumed inhibitor of the monomeric GTPase ADP ribosylation factor 6 (ARF6) and inhibits smooth muscle contraction outside the cardiovascular system. Its effects on vascular smooth muscle contraction or a possible role of ARF6 in vasocontraction have not yet been examined. Here, we report effects of NAV2729 on neurogenic and agonist-induced contractions in renal interlobar and coronary arteries. Contractions of pig interlobar and coronary arteries were induced in an organ bath by agonists or by electric field stimulation (EFS). Owing to divergent characteristics of both vessel types, EFS-induced contractions were only examined in interlobar arteries, and contractions by agonists acting on muscarinic receptors only in coronary arteries. NAV2729 inhibited frequency-dependent EFS-induced contractions of interlobar arteries. The degree of inhibition was similar using 5 µM and 10 µM NAV2729. Inhibition of EFS-induced contractions was resistant to a nitric oxide synthase inhibitor and to diclofenac. The neurogenic and adrenergic character of EFS-induced contractions was confirmed by inhibition by tetrodotoxin and prazosin. In coronary arteries, NAV2729 (5 µM) inhibited concentration-dependent contractions induced by carbachol and methacholine. Contractions induced by α(1)-adrenergic agonists, endothelin-1, the thromboxane receptor agonist U46619, or serotonin remained unchanged by NAV2729 in both vessel types. NAV2729 inhibits neurogenic contractions in interlobar arteries and contractions induced by cholinergic agonists in coronary arteries. In both vessel types, NAV2729 does not inhibit contractions induced by receptor agonists other than those acting on muscarinic receptors. Addressing effects in other vessels and in other smooth muscle–rich organs merits further attention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00210-022-02218-2. Springer Berlin Heidelberg 2022-02-10 2022 /pmc/articles/PMC8873054/ /pubmed/35141760 http://dx.doi.org/10.1007/s00210-022-02218-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Huang, Ru
Li, Bingsheng
Tamalunas, Alexander
Waidelich, Raphaela
Stief, Christian G.
Hennenberg, Martin
Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729
title Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729
title_full Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729
title_fullStr Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729
title_full_unstemmed Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729
title_short Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729
title_sort inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of adp-ribosylation factor 6, nav2729
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873054/
https://www.ncbi.nlm.nih.gov/pubmed/35141760
http://dx.doi.org/10.1007/s00210-022-02218-2
work_keys_str_mv AT huangru inhibitionofneurogeniccontractionsinrenalarteriesandofcholinergiccontractionsincoronaryarteriesbythepresumedinhibitorofadpribosylationfactor6nav2729
AT libingsheng inhibitionofneurogeniccontractionsinrenalarteriesandofcholinergiccontractionsincoronaryarteriesbythepresumedinhibitorofadpribosylationfactor6nav2729
AT tamalunasalexander inhibitionofneurogeniccontractionsinrenalarteriesandofcholinergiccontractionsincoronaryarteriesbythepresumedinhibitorofadpribosylationfactor6nav2729
AT waidelichraphaela inhibitionofneurogeniccontractionsinrenalarteriesandofcholinergiccontractionsincoronaryarteriesbythepresumedinhibitorofadpribosylationfactor6nav2729
AT stiefchristiang inhibitionofneurogeniccontractionsinrenalarteriesandofcholinergiccontractionsincoronaryarteriesbythepresumedinhibitorofadpribosylationfactor6nav2729
AT hennenbergmartin inhibitionofneurogeniccontractionsinrenalarteriesandofcholinergiccontractionsincoronaryarteriesbythepresumedinhibitorofadpribosylationfactor6nav2729